StockStory.org on MSN
Life sciences tools & services stocks Q1 results: Benchmarking Illumina (NASDAQ:ILMN)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Abstract: Colorectal cancer is one of the most common cancers with the second highest mortality rate in the world. The microarray can be used to collect gene expression alteration information from ...
Objective Fibrosis is a common feature of Crohn’s disease (CD) which can involve the mesenteric fat. However, the molecular signature of this process remains unclear. Our goal was to define the ...
Every scientist working with DNA ultimately needs to do one of two things—read or write the nucleotide sequence. Emily Leproust wants nothing less than to make Twist Bioscience the best at writing DNA ...
Early Completion of Model-Assisted Designs for Dose-Finding Trials Accurate assessment of a molecular classifier that guides patient care is of paramount importance in precision oncology. Recent years ...
Microarrays can be a cost-effective alternative to high-throughput sequencing for discovering novel single-nucleotide polymorphisms (SNPs). Illumina’s iScan platform dominates the market, but their ...
Denervation induces skeletal muscle atrophy, accompanied by complex biochemical and physiological changes, with potentially devastating outcomes even an increased mortality. Currently, however, there ...
The rupture of intracranial aneurysm (IA) causes subarachnoid hemorrhage associated with high morbidity and mortality. We compared gene expression profiles in aneurysmal domes between unruptured IAs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results